top of page
About Us
Based on the cutting-edge technology, we are ahead of the next generation molecular diagnostic market.
Overview
BioTNS Co., Ltd. is a company specializing in next-generation molecular diagnosis.
For the first time in Korea, we have a total line-up of Droplet Digital PCR equipment, consumables, and diagnostic reagents, and are entering the global market.
* Securing approval from the Ministry of Food and Drug Safety in 2021
We’re leading the global molecular diagnostic equipment market, including medical equipment and diagnostic reagents.
Since 2011, we have developed equipment and diagnostic reagent technology in the field of digital PCR, and have registered and applied for more than 55 patents.
As a platform company in the field of precision diagnosis, we are growing into a unicorn company.
As a molecular diagnosis platform company, a core field of next-generation precision medicine, we are increasing our corporate value by entering the global market.
Appliances
5+
History
12years+
Diagnostics reagents
120+
Government R&D assignment
20+ , US$ 10Mil +
Patents
55+
Asset
US$ 10Mil +
* As of February 2023 *
bottom of page